The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes in advanced melanoma patients treated with first-line nivolumab plus ipilimumab.
 
Katarzyna Kozak
Consulting or Advisory Role - MSD
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Novartis
 
Pawel Teterycz
Travel, Accommodations, Expenses - MSD; PharmaMar
 
Łukasz Galus
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Jacek Mackiewicz
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis
 
Katarzyna Galwas-Kliber
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Grażyna Kamińska-Winciorek
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Piotr Brandys
No Relationships to Disclose
 
Bozena Cybulska-Stopa
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - MSD; Novartis; Pierre Fabre
 
Natasza Kempa-Kamińska
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Marcin Zietek
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Justyna Żubrowska
No Relationships to Disclose
 
Robert Dziura
No Relationships to Disclose
 
Mateusz Dembiński
No Relationships to Disclose
 
Michał Bereza
No Relationships to Disclose
 
Anna Malgorzata Czarnecka
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre